| |
OR
|
(95% CI)
|
P
|
|---|
|
Recurrence score
| | |
0.06
|
|
Low or intermediate (ref)
| | | |
|
High
|
0.49
|
(0.23–1.03)
| |
|
Age at diagnosis, years
| | |
0.08
|
|
24–39
|
0.36
|
(0.14–0.90)
| |
|
40–49
|
1.18
|
(0.72–1.92)
| |
|
50–59 (ref)
| | | |
|
60–63
|
1.23
|
(0.69–2.19)
| |
|
Stage
| | |
0.48
|
|
I
|
1.22
|
(0.70–2.12)
| |
|
II (ref)
| | | |
|
Chemotherapy
| | |
0.33
|
|
Yes
| | | |
|
No (ref)
|
1.29
|
(0.77–2.15)
| |
|
Histological grade
| | |
0.84
|
|
1–2 (well/moderately differentiated) (ref)
| | | |
|
3 (poorly or not differentiated)
|
1.06
|
(0.58–1.95)
| |
|
Nodal involvement
| | |
0.58
|
|
N0 (ref)
| | | |
|
N1mic/N1
|
1.27
|
(0.54–2.99)
| |
|
Surgery type
| | |
<0.001
|
|
Breast-conserving surgery
|
3.75
| | |
|
Unilateral mastectomy (ref)
| | | |
- Nodal involvement: N0 no cancer in the lymph nodes; N1mic lymph node cancer that can only be seen under a microscope (<2 mm in size); N1 cancer at least 2 mm in size in at least one of three axillary lymph nodes
